GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 98 filers reported holding GENERATION BIO CO in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,616,878 | -34.0% | 690,469 | -4.2% | 0.00% | 0.0% |
| Q2 2023 | $3,965,248 | +33.7% | 720,954 | +4.6% | 0.00% | 0.0% |
| Q1 2023 | $2,965,018 | -5.9% | 689,539 | -14.0% | 0.00% | 0.0% |
| Q4 2022 | $3,151,841 | -27.2% | 801,995 | -1.7% | 0.00% | 0.0% |
| Q3 2022 | $4,330,000 | +208.8% | 815,576 | +281.8% | 0.00% | – |
| Q2 2022 | $1,402,000 | -6.9% | 213,622 | +4.1% | 0.00% | – |
| Q1 2022 | $1,506,000 | +199.4% | 205,168 | +189.0% | 0.00% | – |
| Q4 2021 | $503,000 | -94.3% | 70,990 | -79.7% | 0.00% | -100.0% |
| Q3 2021 | $8,750,000 | -14.1% | 349,034 | -7.8% | 0.00% | 0.0% |
| Q2 2021 | $10,185,000 | -31.7% | 378,623 | -27.8% | 0.00% | -50.0% |
| Q1 2021 | $14,923,000 | +217.1% | 524,356 | +215.9% | 0.00% | +300.0% |
| Q4 2020 | $4,706,000 | +1928.4% | 165,985 | +2107.0% | 0.00% | – |
| Q3 2020 | $232,000 | -79.0% | 7,521 | -85.7% | 0.00% | – |
| Q2 2020 | $1,105,000 | – | 52,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |